AIMD vs. HILS, HEPA, ASLN, PTIX, BFRI, IBIO, XBIO, PULM, SHPH, and VAXX
Should you be buying Ainos stock or one of its competitors? The main competitors of Ainos include Hillstream BioPharma (HILS), Hepion Pharmaceuticals (HEPA), ASLAN Pharmaceuticals (ASLN), Protagenic Therapeutics (PTIX), Biofrontera (BFRI), iBio (IBIO), Xenetic Biosciences (XBIO), Pulmatrix (PULM), Shuttle Pharmaceuticals (SHPH), and Vaxxinity (VAXX). These companies are all part of the "pharmaceutical preparations" industry.
Ainos (NASDAQ:AIMD) and Hillstream BioPharma (NASDAQ:HILS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends, community ranking and earnings.
Hillstream BioPharma received 1 more outperform votes than Ainos when rated by MarketBeat users.
In the previous week, Ainos had 4 more articles in the media than Hillstream BioPharma. MarketBeat recorded 4 mentions for Ainos and 0 mentions for Hillstream BioPharma. Ainos' average media sentiment score of 0.20 beat Hillstream BioPharma's score of 0.00 indicating that Ainos is being referred to more favorably in the media.
Ainos has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Hillstream BioPharma has a beta of 3.08, meaning that its stock price is 208% more volatile than the S&P 500.
Hillstream BioPharma has lower revenue, but higher earnings than Ainos.
Hillstream BioPharma has a net margin of 0.00% compared to Ainos' net margin of -15,348.14%. Ainos' return on equity of -55.38% beat Hillstream BioPharma's return on equity.
13.4% of Hillstream BioPharma shares are owned by institutional investors. 4.6% of Ainos shares are owned by company insiders. Comparatively, 30.2% of Hillstream BioPharma shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Summary
Hillstream BioPharma beats Ainos on 6 of the 11 factors compared between the two stocks.
Get Ainos News Delivered to You Automatically
Sign up to receive the latest news and ratings for AIMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AIMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
